| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $581K | -96.8% | -98.8% |
| R&D Expense | $28.1M | +3.9% | +1.5% |
| SG&A Expense | $8.0M | -12.0% | -27.7% |
| Operating Income | -$35.6M | -99.1% | -434.4% |
| Pre-tax Income | -$35.1M | -75.8% | -426.1% |
| Income Tax | -$161K | -696.3% | -283.0% |
| Net Income | -$34.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $29.6M | -22.8% | -24.5% |
| Accounts Receivable | $523K | +40.6% | -95.0% |
| Current Assets | $44.1M | -11.7% | -24.2% |
| Total Assets | $88.6M | -9.1% | -20.3% |
| Current Liabilities | $50.1M | +5.2% | +16.1% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$72.8M | — | — |
| Capital Expenditures | $88K | — | — |
| Investing Cash Flow | -$88K | — | — |
| Financing Cash Flow | $56.0M | — | — |
| Free Cash Flow | -$72.9M | — | — |
| -74.8% |
| -427.3% |
| EPS (Basic) | -$0.11 | -37.5% | -320.0% |
| EPS (Diluted) | -$0.11 | -37.5% | -375.0% |
| $82.4M |
| +5.7% |
| +14.2% |
| Stockholders' Equity | $6.2M | -68.2% | -84.0% |